# The Impact of Remimazolam Tosilate on Oxygenation and Postoperative Cognitive Function in Elderly Patients Undergoing Thoracoscopic Lobectomy

> **NCT07086911** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Jinqiao Qian** · enrollment: 150 (estimated)

## Conditions studied

- Remimazolam Besylate
- Thoracoscopic Lobectomy
- Oxygenation
- Postoperative Cognitive Dysfunction

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT07086911
- **Lead sponsor:** Jinqiao Qian
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2026-08
- **Final completion:** 2026-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07086911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07086911, "The Impact of Remimazolam Tosilate on Oxygenation and Postoperative Cognitive Function in Elderly Patients Undergoing Thoracoscopic Lobectomy". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT07086911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*